Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Medis logo — Out-Licensing Generic Pharmaceuticals, here for you since 19...

Medis

Out-Licensing Generic Pharmaceuticals, here for you since 1985

Founded 1985 Iceland Iceland 178 employees Biotechnology, Health Care +3

General Information

Company Name Medis
Founded Year 1985
Location Iceland Iceland +8
Employees 178
Industries Biotechnology, Health Care, Life Sciences +2
Social

Get notified when Medis moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Medis

Medis is a company established in 1985 that specializes in out-licensing high-quality generic pharmaceuticals to third-party pharmaceutical companies. With a broad portfolio of 185 generic pharmaceutical products, primarily in the form of tablets, capsules, and injections, Medis has a growing range of specialist oncology products and product formulations, predominantly solid oral dosages. The company has a proven track record in securing regulatory approval prior to patent expiries and has supported its customers in obtaining marketing authorizations in over 140 countries. As a subsidiary of Teva Pharmaceutical Industries Ltd, Medis benefits from their development and manufacturing capabilities, as well as their in-house experts. Medis prides itself on building strong and lasting relationships with its customers over 35 years. Their focus on technical excellence and compliance, combined with the backing from Teva Pharmaceutical Industries, positions Medis as a reliable partner in the pharmaceutical industry.

Taxonomy: Generic pharmaceuticals, Out-licensing, Regulatory support, Oncology products, Intellectual property, Solid oral dosage, Business development, Specialty pharmaceuticals, Manufacturing capabilities, Tablets, Capsules, Injections, Marketing authorizations, Parent company support

No funding data available for Medis yet.

Get notified when Medis raises funding

Medis Alternatives & Competitors

Medis vs
TopRx
TopRx United States

Our products are generic. We're not.

212 employees
Logistics, Logistics and Delivery
Medis vs
Inventia Healthcare Limited
Inventia Healthcare Limited India

Inventia, established in 1985, is a privately held pharmaceutical development and manufacturing comp...

Private Equity
932 employees
Health Care, Manufacturing
Medis vs
Key Pharmaceuticals Limited
Key Pharmaceuticals Limited United Kingdom

Your trusted source for essential pharmaceuticals, delivering a comprehensive range of critical medi...

25 employees
Manufacturing, Pharmaceutical

FAQ About Medis

Out-Licensing Generic Pharmaceuticals, here for you since 1985
Medis was founded in 1985.
Medis is headquartered in Iceland.
Medis operates in the following industries: Biotechnology, Health Care, Life Sciences, Manufacturing, Medical Devices.
Medis has approximately 178 employees.
Top alternatives and competitors to Medis include TopRx, Inventia Healthcare Limited, Key Pharmaceuticals Limited, Genuone Sciences, Pharmox LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medis and TopRx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Medis and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes